Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test

  • M. T. Nüesch-Inderbinen
  • H. Hächler
  • F. H. Kayser


A highly sensitive and specific method, termed PCR/NheI, for the detection of genes coding for SHV extended-spectrum β-lactamases (ESBL) in clinical isolates is presented. It is based on polymerase chain reaction (PCR) amplification of theblaSHV genes, followed by restriction withNheI. Due to the glycine (position 238) (SHV-non-ESBL) → serine (position 238) (SHV-ESBL) mutation, only PCR fragments from the genes coding for SHV-ESBLs were cleaved. A commercially available test for ESBLs, the E test ESBL, identified 52% of our 29 clinical isolates carryingblaSHV-ESBL genes as ESBL producers.


  1. 1.
    Jacoby GA, Carreras I: Activities of β-lactam antibiotics againstEscherichia coli strains producing extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 1990, 34: 858–862.PubMedGoogle Scholar
  2. 2.
    Philippon A, Labia R, Jacoby GA: Extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 1989, 33: 1131–1136.PubMedGoogle Scholar
  3. 3.
    Ambler RP: The structure of β-lactamases. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 1980, 289: 321–331.Google Scholar
  4. 4.
    Kliebe C, Nies B, Meyer JF, Tolxdorff-Neuzling RM, Wiedemann B: Evolution of plasmid-encoded resistance to broad-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 1985, 28: 302–307.PubMedGoogle Scholar
  5. 5.
    Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Dura J: Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multi-resistantKlebsiella pneumoniae. Lancet 1987, ii: 302–306.Google Scholar
  6. 6.
    Sirot D, Sirot J, Labia R, Morand A, Courvalin P, Darfeuille-Michaud A, Perroux R, Cluzel R: Transferable resistance to third generation cephalosporins in clinical isolates ofKlebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. Journal of Antimicrobial Chemotherapy 1987, 20: 323–334.PubMedGoogle Scholar
  7. 7.
    Jacoby GA, Medeiros AA, O'Brien TF, Pinto ME, Jiang J: Broad-spectrum transmissible β-lactamases. New England Journal of Medicine 1989, 319: 723.Google Scholar
  8. 8.
    Quinn JR Miashiro D, Sahm D, Flamm R, Bush K: Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates ofKlebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 1989, 33: 1451–1456.PubMedGoogle Scholar
  9. 9.
    Jacoby GA, Medeiros AA: More extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 1991, 35: 1697–1704.PubMedGoogle Scholar
  10. 10.
    Jarlier V, Nicolas M-H, Fournier G, Philippon A: Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents inEnterobacteriaceae: hospital prevalence and susceptibility patterns. Reviews of Infectious Diseases 1988, 10: 867–878.PubMedGoogle Scholar
  11. 11.
    Thomson KS, Sanders CC: Detection of extended-spectrum beta-lactamases in members of the familyEnterobacteriaceae — comparison of the double-disk and 3-dimensional tests. Antimicrobial Agents and Chemotherapy 1992, 36: 1877–1882.PubMedGoogle Scholar
  12. 12.
    Philippon A, Arlet G, Lagrange PH: Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. European Journal of Clinical Microbiology & Infectious Diseases 1995, 13, Supplement 1: 17–29.Google Scholar
  13. 13.
    Bush K, Jacoby GA, Medeiros AA: A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy 1995, 39: 1211–1233.PubMedGoogle Scholar
  14. 14.
    Arlet G, Rouveau M, Bengoufa D, Nicolas MH, Philippon A: Novel transferable extended-spectrum β-lactamase (SHV-6) fromKlebsiella pneumoniae conferring selective resistance to ceftazidime. FEMS Microbiology Letters 1991, 81:57–62.Google Scholar
  15. 15.
    Bradford PA, Urban C, Jaiswal A, Mariano N, Rasmussen BA, Projan SJ, Rahal JJ, Bush K: SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified inEscherichia coli isolates from hospitalized nursing home patients. Antimicrobial Agents and Chemotherapy 1995, 39: 899–905.PubMedGoogle Scholar
  16. 16.
    Buré A, Legrand R Arlet G, Jarlier V, Paul G, Philippon A: Dissemination in five French hospitals ofKlebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. European Journal of Clinical Microbiology 1988, 7: 780–782.Google Scholar
  17. 17.
    Gutmann L, Ferré B, Goldstein FW, Rizk N, Pinto-Schuster E, Acar JF, Collatz E: SHV-5, a novel SHV-type β-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrobial Agents and Chemotherapy 1989, 33: 951–956.PubMedGoogle Scholar
  18. 18.
    Nicolas M-H, Jarlier V, Honore N, Philippon A, Cole ST: Molecular characterization of the gene encoding SHV-3 β-lactamase responsible for transferable cefotaxime resistance in clinical isolates ofKlebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 1989, 33: 2096–2100.PubMedGoogle Scholar
  19. 19.
    Podbielski A, Schonling J, Melzer B, Warnatz K: Molecular cloning and nucleotide sequence of a new plasmid-codedKlebsiella pneumoniae beta-lactamase gene (SHV-2a) responsible for high-level cefotaxime resistance. International Journal of Medical Microbiology 1991, 275: 369–373.PubMedGoogle Scholar
  20. 20.
    Ambler RR Coulson FW, Frère J-M, Ghuysen J-M, Joris B, Forsman M, Levesque RC, Tiraby G, Waley SG: A standard numbering scheme for the class A β-lactamases. Biochemical Journal 1991, 276: 269–270.PubMedGoogle Scholar
  21. 21.
    Nüesch-Inderbinen MT, Hächler H, Kayser FH: New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV β-lactamases. Antimicrobial Agents and Chemotherapy 1995, 39: 1726–1730.PubMedGoogle Scholar
  22. 22.
    Anonymous: Problems in testing for β-lactamases still unsettled. American Society for Microbiology News 1995, 61: 391–392.Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • M. T. Nüesch-Inderbinen
    • 1
  • H. Hächler
    • 1
  • F. H. Kayser
    • 1
  1. 1.Department of Medical MicrobiologyUniversity of ZürichZürichSwitzerland

Personalised recommendations